{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T07:37:33Z","timestamp":1792654653241,"version":"4.5.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:00:00Z","timestamp":1792627200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:00:00Z","timestamp":1792627200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100014718","name":"Innovative Research Group Project of the National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82330059"],"award-info":[{"award-number":["82330059"]}],"id":[{"id":"10.13039\/100014718","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014718","name":"Innovative Research Group Project of the National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82271965"],"award-info":[{"award-number":["82271965"]}],"id":[{"id":"10.13039\/100014718","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019155","name":"Nanjing Drum Tower Hospital","doi-asserted-by":"publisher","award":["2023-LCYJ-MS11"],"award-info":[{"award-number":["2023-LCYJ-MS11"]}],"id":[{"id":"10.13039\/501100019155","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019155","name":"Nanjing Drum Tower Hospital","doi-asserted-by":"publisher","award":["XJSFZLX202333"],"award-info":[{"award-number":["XJSFZLX202333"]}],"id":[{"id":"10.13039\/501100019155","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019155","name":"Nanjing Drum Tower Hospital","doi-asserted-by":"publisher","award":["RC2022-023"],"award-info":[{"award-number":["RC2022-023"]}],"id":[{"id":"10.13039\/501100019155","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013058","name":"Jiangsu Provincial Key Research and Development Program","doi-asserted-by":"publisher","award":["BE2022679"],"award-info":[{"award-number":["BE2022679"]}],"id":[{"id":"10.13039\/501100013058","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1007\/s00415-026-14156-7","type":"journal-article","created":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T06:37:35Z","timestamp":1792651055000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Dynamic long-term modulation of cognition, brain structure and covariance networks in mild cognitive impairment due to AD by donepezil: A 36-month longitudinal study"],"prefix":"10.1007","volume":"273","author":[{"given":"Yingxin","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhichao","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haocheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinru","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaming","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixuan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8185-8575","authenticated-orcid":false,"given":"Jiu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7592-1195","authenticated-orcid":false,"given":"Bing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,22]]},"reference":[{"issue":"1","key":"14156_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-021-00269-y","volume":"7","author":"DS Knopman","year":"2021","unstructured":"Knopman DS, Amieva H, Petersen RC et al (2021) Alzheimer disease. Nat Rev Dis Primers 7(1):33. https:\/\/doi.org\/10.1038\/s41572-021-00269-y","journal-title":"Nat Rev Dis Primers"},{"key":"14156_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2025.102990","volume":"114","author":"PS Baviskar","year":"2025","unstructured":"Baviskar PS, Mahajan HS (2025) Unveiling Alzheimer\u2019s disease (1901\u20132025): Historical insights, global burden, biological mechanisms, diagnostics, and therapeutic strategies. Ageing Res Rev 114:102990. https:\/\/doi.org\/10.1016\/j.arr.2025.102990","journal-title":"Ageing Res Rev"},{"issue":"10","key":"14156_CR3","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1056\/NEJMoa1106668","volume":"366","author":"R Howard","year":"2012","unstructured":"Howard R, McShane R, Lindesay J et al (2012) Donepezil and memantine for moderate-to-severe Alzheimer\u2019s disease. N Engl J Med 366(10):893\u2013903. https:\/\/doi.org\/10.1056\/NEJMoa1106668","journal-title":"N Engl J Med"},{"issue":"9516","key":"14156_CR4","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1016\/s0140-6736(06)68350-5","volume":"367","author":"B Winblad","year":"2006","unstructured":"Winblad B, Kilander L, Eriksson S et al (2006) Donepezil in patients with severe Alzheimer\u2019s disease: double-blind, parallel-group, placebo-controlled study. Lancet 367(9516):1057\u20131065. https:\/\/doi.org\/10.1016\/s0140-6736(06)68350-5","journal-title":"Lancet"},{"key":"14156_CR5","doi-asserted-by":"publisher","unstructured":"Birks J S and Harvey R J 2018 Donepezil for dementia due to Alzheimer's disease. Cochrane Database Syst Rev, 6 6 Cd001190. https:\/\/doi.org\/10.1002\/14651858.CD001190.pub3.","DOI":"10.1002\/14651858.CD001190.pub3"},{"key":"14156_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2024.102414","volume":"100","author":"OF Sultana","year":"2024","unstructured":"Sultana OF, Bandaru M, Islam MA et al (2024) Unraveling the complexity of human brain: Structure, function in healthy and disease states. Ageing Res Rev 100:102414. https:\/\/doi.org\/10.1016\/j.arr.2024.102414","journal-title":"Ageing Res Rev"},{"key":"14156_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2021.705030","volume":"13","author":"F Feng","year":"2021","unstructured":"Feng F, Huang W, Meng Q et al (2021) Altered volume and structural connectivity of the hippocampus in Alzheimer\u2019s disease and amnestic mild cognitive impairment. Front Aging Neurosci 13:705030. https:\/\/doi.org\/10.3389\/fnagi.2021.705030","journal-title":"Front Aging Neurosci"},{"key":"14156_CR8","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.arr.2016.01.002","volume":"30","author":"L Pini","year":"2016","unstructured":"Pini L, Pievani M, Bocchetta M et al (2016) Brain atrophy in Alzheimer\u2019s disease and aging. Ageing Res Rev 30:25\u201348. https:\/\/doi.org\/10.1016\/j.arr.2016.01.002","journal-title":"Ageing Res Rev"},{"issue":"9","key":"14156_CR9","doi-asserted-by":"publisher","first-page":"3072","DOI":"10.1093\/brain\/awaf151","volume":"148","author":"N Mongay-Ochoa","year":"2025","unstructured":"Mongay-Ochoa N, Gonzalez-Escamilla G, Fleischer V et al (2025) Structural covariance analysis for neurodegenerative and neuroinflammatory brain disorders. Brain 148(9):3072\u20133084. https:\/\/doi.org\/10.1093\/brain\/awaf151","journal-title":"Brain"},{"key":"14156_CR10","doi-asserted-by":"publisher","unstructured":"Dicks E, Vermunt L, van der Flier W M, et al 2020 Grey matter network trajectories across the Alzheimer's disease continuum and relation to cognition. Brain Commun, 2 2 fcaa177. https:\/\/doi.org\/10.1093\/braincomms\/fcaa177.","DOI":"10.1093\/braincomms\/fcaa177"},{"issue":"8","key":"14156_CR11","doi-asserted-by":"publisher","first-page":"5143","DOI":"10.1002\/alz.13859","volume":"20","author":"CR Jack Jr.","year":"2024","unstructured":"Jack CR Jr., Andrews JS, Beach TG et al (2024) Revised criteria for diagnosis and staging of Alzheimer\u2019s disease: Alzheimer\u2019s Association Workgroup. Alzheimers Dement 20(8):5143\u20135169. https:\/\/doi.org\/10.1002\/alz.13859","journal-title":"Alzheimers Dement"},{"key":"14156_CR12","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.neuroimage.2016.07.020","volume":"141","author":"JE Iglesias","year":"2016","unstructured":"Iglesias JE, Van Leemput K, Augustinack J et al (2016) Bayesian longitudinal segmentation of hippocampal substructures in brain MRI using subject-specific atlases. Neuroimage 141:542\u2013555. https:\/\/doi.org\/10.1016\/j.neuroimage.2016.07.020","journal-title":"Neuroimage"},{"key":"14156_CR13","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.neuroimage.2015.04.042","volume":"115","author":"JE Iglesias","year":"2015","unstructured":"Iglesias JE, Augustinack JC, Nguyen K et al (2015) A computational atlas of the hippocampal formation using ex vivo, ultra-high resolution MRI: application to adaptive segmentation of in vivo MRI. Neuroimage 115:117\u2013137. https:\/\/doi.org\/10.1016\/j.neuroimage.2015.04.042","journal-title":"Neuroimage"},{"key":"14156_CR14","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.neuroimage.2017.11.024","volume":"167","author":"JP Fortin","year":"2018","unstructured":"Fortin JP, Cullen N, Sheline YI et al (2018) Harmonization of cortical thickness measurements across scanners and sites. Neuroimage 167:104\u2013120. https:\/\/doi.org\/10.1016\/j.neuroimage.2017.11.024","journal-title":"Neuroimage"},{"key":"14156_CR15","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.neuroimage.2017.08.047","volume":"161","author":"JP Fortin","year":"2017","unstructured":"Fortin JP, Parker D, Tun\u00e7 B et al (2017) Harmonization of multi-site diffusion tensor imaging data. Neuroimage 161:149\u2013170. https:\/\/doi.org\/10.1016\/j.neuroimage.2017.08.047","journal-title":"Neuroimage"},{"issue":"12","key":"14156_CR16","doi-asserted-by":"publisher","first-page":"7719","DOI":"10.1038\/s41380-021-01229-4","volume":"26","author":"Z Liu","year":"2021","unstructured":"Liu Z, Palaniyappan L, Wu X et al (2021) Resolving heterogeneity in schizophrenia through a novel systems approach to brain structure: individualized structural covariance network analysis. Mol Psychiatry 26(12):7719\u20137731. https:\/\/doi.org\/10.1038\/s41380-021-01229-4","journal-title":"Mol Psychiatry"},{"key":"14156_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fnhum.2015.00386","volume":"9","author":"J Wang","year":"2015","unstructured":"Wang J, Wang X, Xia M et al (2015) GRETNA: a graph theoretical network analysis toolbox for imaging connectomics. Front Hum Neurosci 9:386. https:\/\/doi.org\/10.3389\/fnhum.2015.00386","journal-title":"Front Hum Neurosci"},{"issue":"4","key":"14156_CR18","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s00401-006-0127-z","volume":"112","author":"H Braak","year":"2006","unstructured":"Braak H, Alafuzoff I, Arzberger T et al (2006) Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol 112(4):389\u2013404. https:\/\/doi.org\/10.1007\/s00401-006-0127-z","journal-title":"Acta Neuropathol"},{"issue":"6","key":"14156_CR19","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1007\/s00415-018-9016-3","volume":"266","author":"A Chandra","year":"2019","unstructured":"Chandra A, Dervenoulas G, Politis M (2019) Magnetic resonance imaging in Alzheimer\u2019s disease and mild cognitive impairment. J Neurol 266(6):1293\u20131302. https:\/\/doi.org\/10.1007\/s00415-018-9016-3","journal-title":"J Neurol"},{"issue":"12","key":"14156_CR20","doi-asserted-by":"publisher","first-page":"3286","DOI":"10.1093\/brain\/awx243","volume":"140","author":"A Bejanin","year":"2017","unstructured":"Bejanin A, Schonhaut DR, La Joie R et al (2017) Tau pathology and neurodegeneration contribute to cognitive impairment in Alzheimer\u2019s disease. Brain 140(12):3286\u20133300. https:\/\/doi.org\/10.1093\/brain\/awx243","journal-title":"Brain"},{"issue":"1","key":"14156_CR21","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.pscychresns.2011.06.014","volume":"194","author":"SP Poulin","year":"2011","unstructured":"Poulin SP, Dautoff R, Morris JC et al (2011) Amygdala atrophy is prominent in early Alzheimer\u2019s disease and relates to symptom severity. Psychiatry Res 194(1):7\u201313. https:\/\/doi.org\/10.1016\/j.pscychresns.2011.06.014","journal-title":"Psychiatry Res"},{"issue":"9","key":"14156_CR22","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1002\/hbm.20934","volume":"31","author":"SG Mueller","year":"2010","unstructured":"Mueller SG, Schuff N, Yaffe K et al (2010) Hippocampal atrophy patterns in mild cognitive impairment and Alzheimer\u2019s disease. Hum Brain Mapp 31(9):1339\u20131347. https:\/\/doi.org\/10.1002\/hbm.20934","journal-title":"Hum Brain Mapp"},{"key":"14156_CR23","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.neurobiolaging.2020.05.008","volume":"94","author":"E Dicks","year":"2020","unstructured":"Dicks E, van der Flier WM, Scheltens P et al (2020) Single-subject gray matter networks predict future cortical atrophy in preclinical Alzheimer\u2019s disease. Neurobiol Aging 94:71\u201380. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2020.05.008","journal-title":"Neurobiol Aging"},{"key":"14156_CR24","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.neurobiolaging.2017.09.011","volume":"61","author":"BM Tijms","year":"2018","unstructured":"Tijms BM, Ten Kate M, Gouw AA et al (2018) Gray matter networks and clinical progression in subjects with predementia Alzheimer\u2019s disease. Neurobiol Aging 61:75\u201381. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2017.09.011","journal-title":"Neurobiol Aging"},{"key":"14156_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2024.1366761","volume":"18","author":"Y Xiao","year":"2024","unstructured":"Xiao Y, Gao L, Hu Y (2024) Disrupted single-subject gray matter networks are associated with cognitive decline and cortical atrophy in Alzheimer\u2019s disease. Front Neurosci 18:1366761. https:\/\/doi.org\/10.3389\/fnins.2024.1366761","journal-title":"Front Neurosci"},{"key":"14156_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2020.576627","volume":"12","author":"Q Behfar","year":"2020","unstructured":"Behfar Q, Behfar SK, von Reutern B et al (2020) Graph theory analysis reveals resting-state compensatory mechanisms in healthy aging and prodromal Alzheimer\u2019s disease. Front Aging Neurosci 12:576627. https:\/\/doi.org\/10.3389\/fnagi.2020.576627","journal-title":"Front Aging Neurosci"},{"key":"14156_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.nicl.2019.101777","volume":"22","author":"S Skouras","year":"2019","unstructured":"Skouras S, Falcon C, Tucholka A et al (2019) Mechanisms of functional compensation, delineated by eigenvector centrality mapping, across the pathophysiological continuum of Alzheimer\u2019s disease. Neuroimage Clin 22:101777. https:\/\/doi.org\/10.1016\/j.nicl.2019.101777","journal-title":"Neuroimage Clin"},{"issue":"12","key":"14156_CR28","doi-asserted-by":"publisher","first-page":"5890","DOI":"10.1002\/hbm.23772","volume":"38","author":"L Minkova","year":"2017","unstructured":"Minkova L, Habich A, Peter J et al (2017) Gray matter asymmetries in aging and neurodegeneration: a review and meta-analysis. Hum Brain Mapp 38(12):5890\u20135904. https:\/\/doi.org\/10.1002\/hbm.23772","journal-title":"Hum Brain Mapp"},{"issue":"7","key":"14156_CR29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0022153","volume":"6","author":"P Liang","year":"2011","unstructured":"Liang P, Wang Z, Yang Y et al (2011) Functional disconnection and compensation in mild cognitive impairment: evidence from DLPFC connectivity using resting-state fMRI. PLoS ONE 6(7):e22153. https:\/\/doi.org\/10.1371\/journal.pone.0022153","journal-title":"PLoS ONE"},{"key":"14156_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2018.00003","volume":"9","author":"H Liu","year":"2018","unstructured":"Liu H, Zhang L, Xi Q et al (2018) Changes in brain lateralization in patients with mild cognitive impairment and Alzheimer\u2019s disease: a resting-state functional magnetic resonance study from Alzheimer\u2019s Disease Neuroimaging Initiative. Front Neurol 9:3. https:\/\/doi.org\/10.3389\/fneur.2018.00003","journal-title":"Front Neurol"},{"issue":"2","key":"14156_CR31","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.3892\/etm.2017.5613","volume":"15","author":"Y Ma","year":"2018","unstructured":"Ma Y, Ji J, Li G et al (2018) Effects of donepezil on cognitive functions and the expression level of \u03b2-amyloid in peripheral blood of patients with Alzheimer\u2019s disease. Exp Ther Med 15(2):1875\u20131878. https:\/\/doi.org\/10.3892\/etm.2017.5613","journal-title":"Exp Ther Med"},{"issue":"11","key":"14156_CR32","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1176\/appi.ajp.160.11.2003","volume":"160","author":"KR Krishnan","year":"2003","unstructured":"Krishnan KR, Charles HC, Doraiswamy PM et al (2003) Randomized, placebo-controlled trial of the effects of donepezil on neuronal markers and hippocampal volumes in Alzheimer\u2019s disease. Am J Psychiatry 160(11):2003\u20132011. https:\/\/doi.org\/10.1176\/appi.ajp.160.11.2003","journal-title":"Am J Psychiatry"},{"issue":"3","key":"14156_CR33","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1159\/000098052","volume":"23","author":"AK Wallin","year":"2007","unstructured":"Wallin AK, Andreasen N, Eriksson S et al (2007) Donepezil in Alzheimer\u2019s disease: what to expect after 3 years of treatment in a routine clinical setting. Dement Geriatr Cogn Disord 23(3):150\u2013160. https:\/\/doi.org\/10.1159\/000098052","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"5-6","key":"14156_CR34","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1159\/000091790","volume":"21","author":"B Winblad","year":"2006","unstructured":"Winblad B, Wimo A, Engedal K et al (2006) 3-year study of donepezil therapy in Alzheimer\u2019s disease: effects of early and continuous therapy. Dement Geriatr Cogn Disord 21(5\u20136):353\u2013363. https:\/\/doi.org\/10.1159\/000091790","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"1","key":"14156_CR35","doi-asserted-by":"publisher","DOI":"10.1007\/s40520-023-02675-6","volume":"36","author":"G Zuliani","year":"2024","unstructured":"Zuliani G, Zuin M, Romagnoli T et al (2024) Acetyl-cholinesterase-inhibitors reconsidered. A narrative review of post-marketing studies on Alzheimer\u2019s disease. Aging Clin Exp Res 36(1):23. https:\/\/doi.org\/10.1007\/s40520-023-02675-6","journal-title":"Aging Clin Exp Res"},{"issue":"18","key":"14156_CR36","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1212\/01.wnl.0000344650.95823.03","volume":"72","author":"RS Doody","year":"2009","unstructured":"Doody RS, Ferris SH, Salloway S et al (2009) Donepezil treatment of patients with MCI: a 48-week randomized, placebo-controlled trial. Neurology 72(18):1555\u20131561. https:\/\/doi.org\/10.1212\/01.wnl.0000344650.95823.03","journal-title":"Neurology"},{"issue":"5","key":"14156_CR37","doi-asserted-by":"publisher","DOI":"10.1002\/alz.70193","volume":"21","author":"W Liu","year":"2025","unstructured":"Liu W, Li Y, Qin W et al (2025) The impact of cholinesterase inhibitors on cognitive trajectories in mild cognitive impairment patients based on amyloid beta status. Alzheimers Dement 21(5):e70193. https:\/\/doi.org\/10.1002\/alz.70193","journal-title":"Alzheimers Dement"},{"issue":"3-4","key":"14156_CR38","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1159\/000486546","volume":"45","author":"R Knight","year":"2018","unstructured":"Knight R, Khondoker M, Magill N et al (2018) A systematic review and meta-analysis of the effectiveness of acetylcholinesterase inhibitors and memantine in treating the cognitive symptoms of dementia. Dement Geriatr Cogn Disord 45(3\u20134):131\u2013151. https:\/\/doi.org\/10.1159\/000486546","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"45","key":"14156_CR39","doi-asserted-by":"publisher","first-page":"12075","DOI":"10.1073\/pnas.1713308114","volume":"114","author":"VA Carr","year":"2017","unstructured":"Carr VA, Bernstein JD, Favila SE et al (2017) Individual differences in associative memory among older adults explained by hippocampal subfield structure and function. Proc Natl Acad Sci U S A 114(45):12075\u201312080. https:\/\/doi.org\/10.1073\/pnas.1713308114","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"14156_CR40","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1162\/jocn_a_00772","volume":"27","author":"NA Suthana","year":"2015","unstructured":"Suthana NA, Donix M, Wozny DR et al (2015) High-resolution 7T fMRI of human hippocampal subfields during associative learning. J Cogn Neurosci 27(6):1194\u20131206. https:\/\/doi.org\/10.1162\/jocn_a_00772","journal-title":"J Cogn Neurosci"},{"key":"14156_CR41","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.neuroimage.2018.05.041","volume":"178","author":"TE Evans","year":"2018","unstructured":"Evans TE, Adams HHH, Licher S et al (2018) Subregional volumes of the hippocampus in relation to cognitive function and risk of dementia. Neuroimage 178:129\u2013135. https:\/\/doi.org\/10.1016\/j.neuroimage.2018.05.041","journal-title":"Neuroimage"},{"issue":"9","key":"14156_CR42","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1016\/j.jalz.2014.10.003","volume":"11","author":"B Dubois","year":"2015","unstructured":"Dubois B, Chupin M, Hampel H et al (2015) Donepezil decreases annual rate of hippocampal atrophy in suspected prodromal Alzheimer\u2019s disease. Alzheimers Dement 11(9):1041\u20131049. https:\/\/doi.org\/10.1016\/j.jalz.2014.10.003","journal-title":"Alzheimers Dement"},{"issue":"1","key":"14156_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-023-01253-2","volume":"15","author":"P Diaz-Galvan","year":"2023","unstructured":"Diaz-Galvan P, Lorenzon G, Mohanty R et al (2023) Differential response to donepezil in MRI subtypes of mild cognitive impairment. Alzheimers Res Ther 15(1):117. https:\/\/doi.org\/10.1186\/s13195-023-01253-2","journal-title":"Alzheimers Res Ther"},{"issue":"23","key":"14156_CR44","doi-asserted-by":"publisher","first-page":"4224","DOI":"10.1111\/bph.14030","volume":"174","author":"SH Kim","year":"2017","unstructured":"Kim SH, Kandiah N, Hsu JL et al (2017) Beyond symptomatic effects: potential of donepezil as a neuroprotective agent and disease modifier in Alzheimer\u2019s disease. Br J Pharmacol 174(23):4224\u20134232. https:\/\/doi.org\/10.1111\/bph.14030","journal-title":"Br J Pharmacol"},{"issue":"4","key":"14156_CR45","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1002\/jmri.22662","volume":"34","author":"JS Goveas","year":"2011","unstructured":"Goveas JS, Xie C, Ward BD et al (2011) Recovery of hippocampal network connectivity correlates with cognitive improvement in mild Alzheimer\u2019s disease patients treated with donepezil assessed by resting-state fMRI. J Magn Reson Imaging 34(4):764\u2013773. https:\/\/doi.org\/10.1002\/jmri.22662","journal-title":"J Magn Reson Imaging"},{"issue":"3","key":"14156_CR46","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1093\/brain\/awaa012","volume":"143","author":"S Fern\u00e1ndez-Cabello","year":"2020","unstructured":"Fern\u00e1ndez-Cabello S, Kronbichler M, Van Dijk KRA et al (2020) Basal forebrain volume reliably predicts the cortical spread of Alzheimer\u2019s degeneration. Brain 143(3):993\u20131009. https:\/\/doi.org\/10.1093\/brain\/awaa012","journal-title":"Brain"},{"issue":"5 Suppl","key":"14156_CR47","doi-asserted-by":"publisher","first-page":"S344","DOI":"10.1016\/j.jalz.2013.09.011","volume":"10","author":"MJ Grothe","year":"2014","unstructured":"Grothe MJ, Ewers M, Krause B et al (2014) Basal forebrain atrophy and cortical amyloid deposition in nondemented elderly subjects. Alzheimers Dement 10(5 Suppl):S344-353. https:\/\/doi.org\/10.1016\/j.jalz.2013.09.011","journal-title":"Alzheimers Dement"},{"issue":"7","key":"14156_CR48","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1212\/WNL.0b013e318281ccd3","volume":"80","author":"KK Leung","year":"2013","unstructured":"Leung KK, Bartlett JW, Barnes J et al (2013) Cerebral atrophy in mild cognitive impairment and Alzheimer disease: rates and acceleration. Neurology 80(7):648\u2013654. https:\/\/doi.org\/10.1212\/WNL.0b013e318281ccd3","journal-title":"Neurology"},{"issue":"11","key":"14156_CR49","doi-asserted-by":"publisher","first-page":"3039","DOI":"10.1007\/s40520-021-01837-8","volume":"33","author":"M Devita","year":"2021","unstructured":"Devita M, Masina F, Mapelli D et al (2021) Acetylcholinesterase inhibitors and cognitive stimulation, combined and alone, in treating individuals with mild Alzheimer\u2019s disease. Aging Clin Exp Res 33(11):3039\u20133045. https:\/\/doi.org\/10.1007\/s40520-021-01837-8","journal-title":"Aging Clin Exp Res"},{"issue":"11","key":"14156_CR50","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.1831","volume":"10","author":"J Guo","year":"2020","unstructured":"Guo J, Wang Z, Liu R et al (2020) Memantine, Donepezil, or Combination Therapy-What is the best therapy for Alzheimer\u2019s Disease? A Network Meta-Analysis. Brain Behav 10(11):e01831. https:\/\/doi.org\/10.1002\/brb3.1831","journal-title":"Brain Behav"},{"issue":"3","key":"14156_CR51","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.jalz.2011.11.005","volume":"9","author":"S Gauthier","year":"2013","unstructured":"Gauthier S, Molinuevo JL (2013) Benefits of combined cholinesterase inhibitor and memantine treatment in moderate-severe Alzheimer\u2019s disease. Alzheimers Dement 9(3):326\u2013331. https:\/\/doi.org\/10.1016\/j.jalz.2011.11.005","journal-title":"Alzheimers Dement"},{"issue":"3","key":"14156_CR52","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1001\/jama.291.3.317","volume":"291","author":"PN Tariot","year":"2004","unstructured":"Tariot PN, Farlow MR, Grossberg GT et al (2004) Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial. JAMA 291(3):317\u2013324. https:\/\/doi.org\/10.1001\/jama.291.3.317","journal-title":"JAMA"},{"issue":"7","key":"14156_CR53","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010783.pub3","volume":"7","author":"I Arevalo-Rodriguez","year":"2021","unstructured":"Arevalo-Rodriguez I, Smailagic N, Roqu\u00e9-Figuls M et al (2021) Mini-Mental State Examination (MMSE) for the early detection of dementia in people with mild cognitive impairment (MCI). Cochrane Database Syst Rev 7(7):Cd010783. https:\/\/doi.org\/10.1002\/14651858.CD010783.pub3","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-026-14156-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-026-14156-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-026-14156-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T06:37:37Z","timestamp":1792651057000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-026-14156-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,22]]},"references-count":53,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["14156"],"URL":"https:\/\/doi.org\/10.1007\/s00415-026-14156-7","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,22]]},"assertion":[{"value":"8 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","label":"Conflicts of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"ADNI was approved by the Institutional Review Boards of all participating institutions. All ADNI participants provided written informed consent according to the Declaration of Helsinki before study enrollment. The NDTH-ADsnp study was approved by the Ethics Committee of the Nanjing Drum Tower Hospital, and written informed consent was obtained from all subjects prior to enrollment (Approval Number: 2023-341-01). For data collected retrospectively, informed consent from participants was waived following approval by the Ethics Committee of the Nanjing Drum Tower Hospital (Approval Number: 2026\u20130190-01).","order":2,"name":"Ethics","label":"Ethical approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable here.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"677"}}